All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
Requena MB, Protopopescu C, Stewart AC, van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; InCHEHC Collaboration.
Requena MB, et al. Among authors: stewart ac.
Int J Drug Policy. 2024 Feb;124:104311. doi: 10.1016/j.drugpo.2023.104311. Epub 2024 Jan 6.
Int J Drug Policy. 2024.
PMID: 38184902